Ticlopidine and clopidogrel: Antithrombotic agents that block ADP-mediated platelet activation
- 1 April 1994
- journal article
- perspectives
- Published by Springer Nature in Perspectives in Drug Discovery and Design
- Vol. 1 (3) , 521-526
- https://doi.org/10.1007/bf02171863
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Clopidogrel, A Novel Antiplatelet and Antithrombotic AgentCardiovascular Drug Reviews, 1993
- Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.Circulation Research, 1992
- Ticlopidine Treatment Reduces the Progression of Nonproliferative Diabetic RetinopathyArchives of Ophthalmology (1950), 1990
- Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group.Circulation, 1990
- Pharmacology of Ticlopidine: A ReviewSeminars in Thrombosis and Hemostasis, 1989
- TiclopidineDrugs, 1987
- Adenosine diphosphate as a mediator of platelet aggregation in vivo: an editorial view.Circulation, 1985